ReviewEuropean journal of heart failure2022

Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction.

Daniela Tomasoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.